Osteoporosis is a chronic systemic skeletal disease that, at its most serious, cause death. For the proper physiological development of bone tissue, a combination of unnecessary factors is needed.
In recent years, microRNAs have come to the forefront of interest. MicroRNAs are short non-coding RNA molecules that play an important role in posttranscriptional regulation of gene expression.
They also affect bone metabolism, and alterations in their expression may be involved in variety of pathological conditions, including osteoporosis. Recently, there is an increasing number of publications focusing on the detection of specific microRNAs associated with osteoporosis.
In the future, these molecules could serve as useful biomarkers or therapeutic targets.